Literature DB >> 1783380

Major rearrangements in the alpha 5(IV) collagen gene in three patients with Alport syndrome.

E Boye1, D Vetrie, F Flinter, B Buckle, T Pihlajaniemi, E R Hamalainen, J C Myers, M Bobrow, A Harris.   

Abstract

The gene coding for the alpha 5 chian of type IV collagen (alpha 5(IV) collagen), which maps to Xq22, is a candidate gene for the X-linked dominant disease Alport syndrome (AS). Using three cDNA clones, covering the 3' end of the alpha 5(IV) collagen gene, 3 of 38 patients have been identified with mutations in this gene. Each of these patients shows a gross rearrangement of DNA: a deletion of at least 35 kb, an insertion/deletion event involving approximately 25 kb, and a duplication of at least 35 kb of DNA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1783380     DOI: 10.1016/0888-7543(91)90040-l

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  11 in total

1.  The molecular genetics of Alport syndrome: report of two workshops.

Authors:  F Flinter; M Bobrow
Journal:  J Med Genet       Date:  1992-05       Impact factor: 6.318

2.  Alport syndrome: a genetic study of 31 families.

Authors:  R M'Rad; M Sanak; G Deschenes; J Zhou; C Bonaiti-Pellie; L Holvoet-Vermaut; S Heuertz; M C Gubler; M Broyer; J P Grunfeld
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

3.  Alport syndrome caused by inversion of a 21 Mb fragment of the long arm of the X-chromosome comprising exon 9 through 51 of the COL4A5 gene.

Authors:  Jens Michael Hertz; Ulf Persson; Inger Juncker; Mårten Segelmark
Journal:  Hum Genet       Date:  2005-10-28       Impact factor: 4.132

4.  Improving mutation screening in familial hematuric nephropathies through next generation sequencing.

Authors:  Vincent Morinière; Karin Dahan; Pascale Hilbert; Marieline Lison; Said Lebbah; Alexandra Topa; Christine Bole-Feysot; Solenn Pruvost; Patrick Nitschke; Emmanuelle Plaisier; Bertrand Knebelmann; Marie-Alice Macher; Laure-Hélène Noel; Marie-Claire Gubler; Corinne Antignac; Laurence Heidet
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

5.  Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13.

Authors:  A Toren; N Amariglio; G Rozenfeld-Granot; A J Simon; F Brok-Simoni; E Pras; G Rechavi
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

6.  Small frameshift deletions within the COL4A5 gene in juvenile-onset Alport syndrome.

Authors:  A Renieri; M Seri; L Galli; P Cosci; E Imbasciati; L Massella; G Rizzoni; G Restagno; A O Carbonara; E Stramignoni
Journal:  Hum Genet       Date:  1993-10       Impact factor: 4.132

7.  Persistent microscopic haematuria without proteinuria.

Authors:  F A Flinter
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

8.  Genetic aspects of renal dysfunction: Alport's syndrome.

Authors:  F Flinter; E Boye; D Vetrie; A Harris; M Bobrow
Journal:  Clin Investig       Date:  1994-09

9.  X inactivation patterns in females with Alport's syndrome: a means of selecting against a deleterious gene?

Authors:  D Vetrie; F Flinter; M Bobrow; A Harris
Journal:  J Med Genet       Date:  1992-09       Impact factor: 6.318

Review 10.  Mild phenotypic manifestation of a 7p15.3p21.2 deletion.

Authors:  C Wang; S Maynard; T W Glover; L G Biesecker
Journal:  J Med Genet       Date:  1993-07       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.